Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Reviews in Urology|September 21, 2006
E-1899: An Eastern Cooperative Oncology Group Study Comparing Ketoconazole Plus Hydrocortisone with Docetaxel Plus Estramustine for Asymptomatic, Androgen-Independent, Nonmetastatic Prostate Cancer Patients with Rising PSA LevelsRobert Dreicer, Michael Carducci
Expert Opinion on Investigational Drugs|November 30, 2004
Atrasentan: targeting the endothelin axis in prostate cancerAntonio Jimeno, Michael Carducci
Expert Review of Anticancer Therapy|July 9, 2005
Atrasentan: a novel and rationally designed therapeutic alternative in the management of cancerAntonio Jimeno, Michael Carducci
Reviews in Urology|September 21, 2006
E-1899: An Eastern Cooperative Oncology Group Study Comparing Ketoconazole Plus Hydrocortisone with Docetaxel Plus Estramustine for Asymptomatic, Androgen-Independent, Nonmetastatic Prostate Cancer Patients with Rising PSA LevelsRobert Dreicer, Michael Carducci
Drugs of Today (Barcelona, Spain : 1998)|June 28, 2006
Atrasentan: a rationally designed targeted therapy for cancerAntonio Jimeno, Michael Carducci
Palliative & Supportive Care|August 22, 2025
Scrambler therapy for chemotherapy-induced peripheral neuropathy: A case reportZhu Wang, Michael Carducci, Giuseppe Marineo, et al.
Investigational New Drugs|August 26, 2014
An open-label study to determine the maximum tolerated dose of the multitargeted tyrosine kinase inhibitor CEP-11981 in patients with advanced cancerRoberto Pili, Michael Carducci, Peter Brown, et al.
Clinical Advances in Hematology & Oncology : H&O|December 5, 2006
Novel targets in solid tumors: MEK inhibitorsWells A Messersmith, Manuel Hidalgo, Michael Carducci, et al.
Clinical Genitourinary Cancer|March 6, 2012
Phase II trial of weekly ixabepilone in men with metastatic castrate-resistant prostate cancer (E3803): a trial of the Eastern Cooperative Oncology GroupGlenn Liu, Yu-Hui Chen, Robert Dipaola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
State of the translational science: summary of Baltimore workshop on gene re-expression as a therapeutic target in cancer January 2003Arthur Zelent, Samuel Waxman, Michael Carducci, et al.
Pageof 8